Researcher
Debby Thomas
- Disciplines:Laboratory medicine, Regenerative medicine, Other basic sciences, Other health sciences, Other medical and health sciences, Medical biotechnology, Drug discovery and development, Pharmaceutics
Affiliations
- Therapeutic and Diagnostic Antibodies (Division)
Member
From1 Jun 2017 → Today - Gynaecological Oncology (Division)
Member
From1 Mar 2014 → 31 May 2017
Projects
1 - 2 of 2
- Symmetric antibodies for symmetric epitopes: development and validation of the Symbody platform.From1 Oct 2021 → TodayFunding: IOF - technology validation in lab
- Deciphering Tau structure and oligomerization propensities: Towards innovative therapeutics, prognostics and diagnosticsFrom1 Jan 2021 → TodayFunding: IOF - technology validation in lab
Publications
1 - 10 of 34
- Point-of-care therapeutic drug monitoring of adalimumab by integrating a FO-SPR biosensor in a self-powered microfluidic cartridge(2022)
Authors: Henry Ordutowski, Charlotte Van Tricht, Mattijs Bulcaen, Marta Ciwinska, Carolina Gutierrez Cisneros, Xander Janssens, Nick Geukens, Debby Thomas, Francesco Dal Dosso, Dragana Spasic, et al.
Number of pages: 9 - Development and validation of a microfluidic multiplex immunoassay for the determination of levels and avidity of serum antibodies to tetanus, diphtheria and pertussis antigens(2022)
Authors: Debby Thomas, Louanne Ampofo, Nick Geukens, Xavier Bossuyt
Number of pages: 11 - Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases(2022)
Authors: Debby Thomas, Séverine Vermeire, Peter Bossuyt
Pages: 208 - 217Number of pages: 10 - The value of therapeutic drug monitoring to guide treatment optimisation of biologicals in patients with chronic inflammatory diseases: focus on vedolizumab and ustekinumab(2021)
Authors: Nathalie Van den Berghe, Paul Declerck, Séverine Vermeire, Debby Thomas
- Precise sample metering method by coordinated burst action of hydrophobic burst valves applied to dried blood spot collection(2021)
Authors: Dries Vloemans, Lorenz Van Hileghem, Wannes Verbist, Debby Thomas, Francesco Dal Dosso, Jeroen Lammertyn
Pages: 1 - 10 - Ustekinumab Dosing Individualization in Crohn’s Disease Guided by a Population Pharmacokinetic–Pharmacodynamic Model(2021)
Authors: Erwin Dreesen, Debby Thomas
Pages: 1587 - 1587 - Tissue exposure does not explain non-response in ulcerative colitis patients with adequate serum vedolizumab concentrations(2021)
Authors: Nathalie Van den Berghe, Bram Verstockt, João Pedro Guedelha Sabino, Marc Ferrante, Séverine Vermeire, Paul Declerck, Debby Thomas
Pages: 988 - 993 - The effect of aging on infliximab exposure and response in patients with inflammatory bowel diseases(2021)
Authors: Wannee Kantasiripitak, Bram Verstockt, Dahham Alsoud, Debby Thomas, Séverine Vermeire, Marc Ferrante, Erwin Dreesen
Pages: 3776 - 3789Number of pages: 14 - Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn's Disease Likely to Achieve Endoscopic and Biochemical Remission(2021)
Authors: Erwin Dreesen, Debby Thomas
Pages: 111 - +Number of pages: 18 - Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients(2020)
Authors: Debby Thomas, Kristel Van Steen, Marc Hoylaerts, Gert Van Assche, Séverine Vermeire, Marc Ferrante
Pages: 819 - 825Number of pages: 7